STAND. COM. REP. NO. 252-06

Honolulu, Hawaii

, 2006

RE: H.B. No. 3105

H.D. 1

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Third State Legislature

Regular Session of 2006

State of Hawaii

Sir:

Your Committees on Health and Human Services, to which was referred H.B. No. 3105 entitled:

"A BILL FOR AN ACT RELATING TO PSYCHOTROPIC MEDICATION,"

beg leave to report as follows:

The purpose of this bill is to facilitate the effective treatment of mental health consumers by prohibiting the Department of Human Services (DHS) from restricting the physician's ability to treat a fee-for-service patient with psychotropic medications that have been:

(1) Approved by the Food and Drug Administration; and

(2) Considered appropriate and within the lawful scope of the physician's practice and professional judgment.

The Hawaii Disability Rights Center, National Alliance for the Mentally Ill, Oahu, Hawaii Psychiatric Medical Association, and several concerned individuals supported this measure. DHS supported the intent of this measure.

Your Committees find that the ability to treat a person suffering from illness must not be further impeded when strict Food and Drug Administration guidelines are already in place and when a certified medical physician determines a treatment to be safe and effective.

Your Committees have amended this bill by making technical, nonsubstantive changes for clarity, consistency, and style.

As affirmed by the records of votes of the members of your Committees on Health and Human Services that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 3105, as amended herein, and recommend that it pass Second Reading in the form attached hereto as H.B. No. 3105, H.D. 1, and be referred to the Committees on Consumer Protection & Commerce and Judiciary.

Respectfully submitted on behalf of the members of the Committees on Health and Human Services,

 

____________________________

ALEX M. SONSON, Chair

____________________________

DENNIS A. ARAKAKI, Chair